Börsipäev 20. august - Investeerimine - Foorum - LHV finantsportaal

LHV finantsportaal

Foorum Investeerimine

Börsipäev 20. august

Kommentaari jätmiseks loo konto või logi sisse

  • Ilusat taasiseseisvumispäeva kõigile!

    Tänase päeva puhul on suletud ainult Tallinna börs ja kõik teised turud on avatud ikka tavapärasel ajal.
    Kuna nädalavahetus olulisi uudiseid ei toonud, siis on nii USA kui ka Euroopa turud kauplemas plusspoolel.
    USA futuurid on päeva alustamas ca 0,20% kõrgemal ja DAX- kauplemas hetkel 0,8% plussis.

  • Gapping up
    In reaction to strong earnings/guidance:

    CMCM +12.2%, HMI +11.6%
    M&A news:

    SODA +10.2% (to be acquired by PepsiCo (PEP) for $144/share in cash, or approximately $3.2 bln)
    AHL +2.9% (Aspen Insurance said to be nearing a $2.5 bln takeover deal with Apollo (APO), according to Insurance Insider)
    Select China related names showing strength:

    BZUN +2.6%, MOMO +2.2%, JD +1.6%, SINA +1.5%
    Select metals/mining stocks trading higher:

    AU +2.9%, FCX +1.5%, BBL +1.3%, MT +1.3%, BHP +1.1%, ABX +1%
    Other news:

    ALXN +2.1% (announces that the FDA has accepted for priority review the Biologics License Application for ALXN1210)
    RDHL +1.8% (received a Notice of Allowance from the USPTO for a new formulation patent covering RHB-106)
    AZN +1% (advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018)
    BA +0.5% (awarded $217 mln Defense Logistics Agency Aviation contract with Dec 30, 2022 performance completion date and $152 mln Navy contract)
    Analyst comments:

    MIXT +6.9% (upgraded to Strong Buy from Outperform at Raymond James)
    TEX +2.5% (upgraded to Neutral from Underperform at Robert W. Baird)
    NKE +2.3% (upgraded to Overweight from Neutral at Piper Jaffray)
    QCOM +0.5% (upgraded to Buy from Neutral at Rosenblatt)
    Gapping down
    In reaction to disappointing earnings/guidance:

    EL -1.4%, SSL -0.8%
    Other news:

    LCI -42.6% (issues guidance - distribution agreement with Jerome Stevens Pharmaceuticals will not be renewed)
    TSLA -4.7% (continued weakness)
    Analyst comments:

    STZ -1.9% (downgraded to Negative from Neutral at Susquehanna)


Teemade nimekirja


Et pakkuda sulle parimat kasutajakogemust, kasutame LHV veebilehel küpsiseid. Valides "Nõustun", annad nõusoleku kõikide küpsiste kasutamiseks. Tutvu küpsiste kasutamise põhimõtetega.